FD
Publicaties op Oncologisch.com
Savolitinib plus osimertinib in epidermal growth factor receptor (EGFR)-mutated gevorderd non-small cell lung cancer ...
A randomised phase III study of bevacizumab and carboplatin-pemetrexed chemotherapy with or without atezolizumab as e...
Sitravatinib plus nivolumab versus docetaxel bij plaveiselcel NSCLC: SAPPHIRE fase III
EGFR-gemuteerd NSCLC: ESMO expertconsensus